Physicians Realty Trust - DOC Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $15.33
  • Forecasted Upside: 34.86%
  • Number of Analysts: 9
  • Breakdown:
  • 1 Sell Ratings
  • 6 Hold Ratings
  • 2 Buy Ratings
  • 0 Strong Buy Ratings
$11.37
▼ -0.21 (-1.81%)

This chart shows the closing price for DOC by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Physicians Realty Trust Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for DOC and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for DOC

Analyst Price Target is $15.33
▲ +34.86% Upside Potential
This price target is based on 9 analysts offering 12 month price targets for Physicians Realty Trust in the last 3 months. The average price target is $15.33, with a high forecast of $18.00 and a low forecast of $14.00. The average price target represents a 34.86% upside from the last price of $11.37.

This chart shows the closing price for DOC for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Hold

The current consensus among 9 polled investment analysts is to hold stock in Physicians Realty Trust. This Hold consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 2 buy ratings
  • 6 hold ratings
  • 1 sell ratings
8/30/2022
  • 0 strong buy ratings
  • 2 buy ratings
  • 6 hold ratings
  • 1 sell ratings
11/28/2022
  • 0 strong buy ratings
  • 2 buy ratings
  • 6 hold ratings
  • 1 sell ratings
2/26/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 6 hold ratings
  • 1 sell ratings
5/27/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 6 hold ratings
  • 1 sell ratings
8/25/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 6 hold ratings
  • 1 sell ratings
11/23/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 6 hold ratings
  • 1 sell ratings
1/22/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 6 hold ratings
  • 1 sell ratings
2/21/2024

Latest Recommendations

  • 0 strong buy ratings
  • 2 buy ratings
  • 6 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/5/2024KeyCorpReiterated RatingOverweight ➝ Sector WeightLow
1/2/2024Compass PointLower TargetBuy ➝ Buy$19.00 ➝ $18.00Low
12/22/2023Truist FinancialLower TargetHold ➝ Hold$15.00 ➝ $14.00Low
8/22/2023CitigroupLower TargetNeutral ➝ Neutral$15.00 ➝ $14.00Low
8/16/2023Truist FinancialReiterated RatingHold ➝ Hold$15.00Low
8/7/2023Wells Fargo & CompanyBoost TargetUnderweight ➝ Underweight$14.00 ➝ $15.00Low
7/20/2023Morgan StanleyReiterated RatingEqual Weight ➝ Equal Weight$14.50Low
5/26/2023JMP SecuritiesInitiated CoverageOutperform$15.50Low
5/5/2023BarclaysLower Target$18.00 ➝ $17.00Low
4/19/2023Wells Fargo & CompanyInitiated CoverageUnderweight$14.00Low
3/29/2023Credit Suisse GroupReiterated RatingNeutral$15.00Low
3/27/2023Compass PointLower TargetBuy$21.00 ➝ $19.00Low
2/28/2023Royal Bank of CanadaLower TargetSector Perform$16.00 ➝ $15.00Low
12/14/2022KeyCorpUpgradeSector Weight ➝ Overweight$17.00Low
11/1/2022Morgan StanleyLower TargetEqual Weight$16.50 ➝ $14.50Low
10/28/2022JPMorgan Chase & Co.Initiated CoverageNeutral$17.00Low
8/31/2022Morgan StanleyBoost TargetEqual Weight$16.00 ➝ $16.50Low
8/22/2022CitigroupBoost Target$19.00Low
8/5/2022Colliers SecuritiesDowngradeBuy ➝ Neutral$19.00Low
7/15/2022Morgan StanleyLower TargetEqual Weight$17.50 ➝ $16.00Low
7/11/2022Truist FinancialLower TargetHold$18.00 ➝ $17.00N/A
6/30/2022Jefferies Financial GroupLower TargetBuy$21.00 ➝ $20.00Low
6/3/2022Capital One FinancialInitiated CoverageEqual Weight ➝ Equal Weight$20.00Low
6/1/2022Morgan StanleyLower TargetEqual Weight$18.00 ➝ $17.50Low
5/19/2022Bank of AmericaDowngradeNeutral ➝ Underperform$18.00Low
4/26/2022BarclaysInitiated CoverageOverweight$20.00Low
3/9/2022Royal Bank of CanadaLower TargetSector Perform$19.00 ➝ $18.00Low
3/7/2022Morgan StanleyLower TargetEqual Weight$19.00 ➝ $18.00Medium
2/24/2022Colliers SecuritiesReiterated RatingBuy$20.00Medium
2/1/2022Credit Suisse GroupInitiated CoverageNeutral$19.00Medium
1/7/2022BMO Capital MarketsDowngradeOutperform ➝ Market Perform$20.00Low
11/29/2021Morgan StanleyLower TargetEqual Weight$20.00 ➝ $19.00Low
10/7/2021BMO Capital MarketsBoost TargetMarket Perform$32.50 ➝ $35.00Low
9/13/2021Morgan StanleyDowngradeOverweight ➝ Equal Weight$20.00Low
8/20/2021Raymond JamesDowngradeOutperform ➝ Market PerformMedium
7/16/2021Colliers SecuritiesReiterated RatingBuy$21.00Medium
6/14/2021Robert W. BairdDowngradeOutperform ➝ Neutral$19.00 ➝ $20.00Low
3/15/2021Morgan StanleyUpgradeEqual Weight ➝ Overweight$20.00High
1/13/2021Jefferies Financial GroupUpgradeHold ➝ Buy$18.00 ➝ $20.00Medium
12/11/2020Morgan StanleyBoost TargetEqual Weight$14.00 ➝ $16.00High
11/11/2020B. RileyReiterated RatingBuyMedium
11/11/2020Royal Bank of CanadaDowngradeOutperform ➝ Sector Perform$20.00Low
9/9/2020Colliers SecuritiesInitiated CoverageBuy$22.00Low
8/31/2020Raymond JamesBoost TargetOutperform$19.00 ➝ $20.00Low
8/7/2020KeyCorpBoost TargetOverweight$18.00 ➝ $20.00Medium
7/2/2020CitigroupBoost TargetNeutral$14.00 ➝ $18.00Low
6/10/2020B. RileyBoost Target$19.00 ➝ $21.00Medium
5/8/2020B. RileyLower TargetBuy$22.00 ➝ $19.00Medium
4/29/2020Raymond JamesLower TargetOutperform$22.00 ➝ $19.00High
4/23/2020SunTrust BanksLower TargetHold$19.00 ➝ $16.00Medium
4/21/2020KeyCorpLower TargetOverweight$22.00 ➝ $18.00High
4/7/2020CitigroupDowngradeBuy ➝ Neutral$21.00 ➝ $14.00Medium
4/1/2020Berenberg BankUpgradeHold ➝ BuyHigh
3/30/2020MizuhoDowngradeHoldMedium
3/26/2020Morgan StanleyLower TargetEqual Weight$18.00 ➝ $14.00High
3/16/2020BTIG ResearchDowngradeBuy ➝ NeutralHigh
3/12/2020Raymond JamesBoost TargetOutperform$20.00 ➝ $22.00High
3/9/2020Royal Bank of CanadaReiterated RatingBuy$22.00High
3/9/2020BMO Capital MarketsUpgradeMarket Perform ➝ Outperform$19.00 ➝ $23.00High
2/27/2020Capital One FinancialUpgradeEqual Weight ➝ Overweight$18.50 ➝ $22.00High
2/27/2020B. RileyBoost TargetBuy$20.00 ➝ $22.00High
1/16/2020KeyCorpBoost TargetOverweight$19.00 ➝ $20.00Medium
12/19/2019MizuhoInitiated CoverageBuy$20.00Low
12/12/2019CitigroupUpgradeNeutral ➝ Buy$18.50 ➝ $21.00High
11/26/2019Stifel NicolausUpgradeHold ➝ Buy$19.00 ➝ $21.00High
11/8/2019B. RileyReiterated RatingBuyLow
10/14/2019Bank of AmericaInitiated CoverageNeutralLow
9/17/2019Morgan StanleyLower TargetEqual Weight$19.00 ➝ $17.50Medium
9/12/2019Berenberg BankInitiated CoverageHold$18.00Low
6/20/2019CitigroupInitiated CoverageNeutral ➝ Neutral$18.50Medium
5/7/2019BMO Capital MarketsDowngradeOutperform ➝ Market Perform$17.45High
5/2/2019Capital One FinancialDowngradeOverweight ➝ Equal Weight$18.75Low
3/28/2019Morgan StanleySet TargetHold$19.00Medium
(Data available from 2/21/2019 forward)

News Sentiment Rating

1.52 (Strong Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 15 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/26/2023
  • 15 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/25/2023
  • 10 very positive mentions
  • 0 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
9/24/2023
  • 6 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/24/2023
  • 3 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
11/23/2023
  • 4 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/23/2023
  • 10 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
1/22/2024
  • 13 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
2/21/2024

Current Sentiment

  • 13 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Physicians Realty Trust logo
Physicians Realty Trust is a self-managed health care real estate company organized to acquire, selectively develop, own, and manage health care properties that are leased to physicians, hospitals, and health care delivery systems. The Company invests in real estate that is integral to providing high quality health care. The Company conducts its business through an UPREIT structure in which its properties are owned by Physicians Realty L.P., a Delaware limited partnership (the operating partnership), directly or through limited partnerships, limited liability companies or other subsidiaries. The Company is the sole general partner of the operating partnership and, as of June 30, 2023, owned approximately 96.0% of OP Units.
Read More

Today's Range

Now: $11.37
Low: $11.31
High: $11.58

50 Day Range

MA: $12.74
Low: $11.33
High: $13.77

52 Week Range

Now: $11.37
Low: $10.52
High: $15.60

Volume

3,058,281 shs

Average Volume

2,439,638 shs

Market Capitalization

$2.71 billion

P/E Ratio

59.85

Dividend Yield

7.94%

Beta

0.87

Frequently Asked Questions

What sell-side analysts currently cover shares of Physicians Realty Trust?

The following Wall Street analysts have issued research reports on Physicians Realty Trust in the last year: Barclays PLC, Citigroup Inc., Compass Point, Credit Suisse Group AG, JMP Securities, KeyCorp, Morgan Stanley, Royal Bank of Canada, StockNews.com, Truist Financial Co., and Wells Fargo & Company.
View the latest analyst ratings for DOC.

What is the current price target for Physicians Realty Trust?

9 Wall Street analysts have set twelve-month price targets for Physicians Realty Trust in the last year. Their average twelve-month price target is $15.33, suggesting a possible upside of 34.9%. Compass Point has the highest price target set, predicting DOC will reach $18.00 in the next twelve months. Truist Financial Co. has the lowest price target set, forecasting a price of $14.00 for Physicians Realty Trust in the next year.
View the latest price targets for DOC.

What is the current consensus analyst rating for Physicians Realty Trust?

Physicians Realty Trust currently has 1 sell rating, 6 hold ratings and 2 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in DOC, but not buy more shares or sell existing shares.
View the latest ratings for DOC.

What other companies compete with Physicians Realty Trust?

How do I contact Physicians Realty Trust's investor relations team?

Physicians Realty Trust's physical mailing address is 309 N. WATER STREET SUITE 500, MILWAUKEE WI, 53202. The real estate investment trust's listed phone number is (414) 367-5600 and its investor relations email address is [email protected]. The official website for Physicians Realty Trust is www.docreit.com. Learn More about contacing Physicians Realty Trust investor relations.